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Abstract. Background/Aim: Breast cancer is associated with
appearance concerns and issues of appearance identity, that
require an appropriate and independent assessment. The
Derriford Appearance Scale (DAS) has been widely used to this
end, as has been shown in UK and other international samples.
The aim of this study was to determine the extent to which an
Italian translation of DAS24 is valid, reliable, and culturally
appropriate, while remaining user friendly. The extent to which
the statistical robustness of the scale is maintained was also
assessed. Patients and Methods: Ninety-three female
participants were recruited at a Breast Cancer Department in
Southern Italy. According to the protocol designed by the
original authors of the questionnaire, a booklet containing the
DAS24ita and other scale was completed anonymously by
participants. Conclusion: The results of the statistical analysis
confirmed the validity and reliability of the DAS24ita. The
DAS24ita demonstrated significant correlations with the other
measures of appearance sensitivity and quality of life. The
translated scale was able to differentiate among patients with
differential diagnoses, and was more sensitive to these
differences than generic quality-of-life scales.
Breast cancer diagnosis is a significantly stressful experience
for women (1, 2). There are a plethora of patient reported
outcomes that assess health-related quality of life and patient
satisfaction with care in breast cancer and other cancer types
[see, for example, Kanatas et al. (3) for a review]. However,
these outcomes typically very broad concerns around cancer
and breast cancer, including satisfaction with treatment, pain,
and other physical symptomatology. Breast cancer is
associated with appearance concerns and issues of
appearance identity, which are somewhat independent of
these factors, and require an appropriate assessment
separately. There is an increasingly apparent need to measure
distress and dysfunction associated with appearance
concerns. Maas et al. describe the need for a 'gold standard'
professional aesthetic assessment scale, recognising that
aesthetic outcomes are subject to poor inter-rater reliability
(4). Furthermore, the lack of consistency between objectively
assessed and subjectively assessed severity of appearance (5)
emphasises the importance of valid and reliable patient-
based, subjective reporting of the impact of appearance
differences. Surgeons in clinical practice, as well as
psychologists, have recognised this. Valid and reliable
measurement tools enable surgical and non-surgical
interventions to contribute to a meaningful evidence basis on
which to address the clinical need and the effectiveness of
therapies post-intervention within the framework of
evidence-based medicine (6-8). The requirements for such a
measure include the need for demonstrable validity and
reliability, evident content validity to ensure that the content
of the measure addresses the condition(s) subject to
investigation, sufficient sensitivity to discriminate amongst
individuals with varying levels of distress, and crucially, be
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user friendly for both patients and clinicians. Most notably,
the Derriford Appearance Scale (9) has been widely used to
this end as it has been shown in UK and other international
samples to meet these criteria.
The longer version of the DAS was translated and
culturally validated in an Italian sample (10). It was
demonstrated that subscales of the DAS59 did produce
internally coherent subtotals based on analysis of internal
scale and subscale validity. The sample size in the dataset did
not, however, permit a confirmatory factor analysis to
determine the extent to which the Italian sample replicated
the UK samples. Overall, the Italian sample demonstrated
significantly more distress and dysfunction as assessed by the
DAS 59 total scores than those for the UK sample. The Italian
sample also demonstrated a difference between the sexes with
respect to total scores, with women more distressed (scoring
higher) than men on the subscales of sexual/bodily self-
consciousness, and social self-consciousness.
The DAS24 is a self-reported questionnaire of 24
questions and statements, each with five response options.
An introductory section collects appropriate demographic
information about the respondent and identifies which, if
any, aspect of appearance is of greatest concern, which is
referred to as the 'feature' in some items. The introductory
section and inclusion of a 'not applicable' response category
for most items render the DAS24 user-friendly for adult
respondents (16 years and older) whether or not they have
an aspect of appearance about which they are concerned. The
scale can be completed in the consulting room, in the waiting
room, or at the patient's home. Successful translations of this
scale have been made into numerous languages: Chinese (11)
and Taiwanese (12); Spanish, Portuguese and Swedish are
ongoing; as well as translation of the previous version (DAS
59) into different languages including Nepalese (13), Italian
(10), Korean (14) and Japanese (15).
The shorter version of the scale (DAS24) has not yet been
subject to the same linguistic translation and validation
procedures in Italian. The aim of this study was to determine
the extent to which an Italian translation is valid, reliable,
culturally appropriate, and user friendly, and also the extent
to which the statistical robustness of the scale is maintained.
In order to validate the measure for use in a clinical
setting, it is obviously important to use a clinical sample
with appearance-altering conditions. To this end, we
hypothesised that there would be differences between the
adjustments to the appearance-altering surgeries of
mastectomy, and quadrantectomy in comparison to each
other. De Feudis et al. investigated breast cancer outcomes
in a Southern Italian sample, comparing patients who
underwent quadrantectomy and mastectomy (16). They
found that mastectomy was associated with comparatively
higher levels of both anxiety and depression. However, this
study was not able to investigate the impact of appearance
on patient outcomes in relation to surgery type. This is
consistent with a large-scale longitudinal study by Engel et
al. on an English-speaking sample (17).
It was hypothesised that the translated version of DAS24
would be comprehensible and meaningful in the Italian
language, and when used clinically would demonstrate
internal consistency, convergent criterion validity through
correlation with known correlates of the DAS24, and
demonstrate concurrent criterion validity by differentiating
preoperative, quadrantectomy, and mastectomy patients. We
also hypothesised that these patient groups would differ
according to other outcomes relevant to appearance
(appearance valence and appearance salience), depression,
anxiety and body shame scores, as well as quality of life.
Patients and Methods
Translation and adaptation method. The Italian translation of the
DAS24 was validated according to the protocol designed by the
original authors of the questionnaire. For the translation, we adopted
an iterative, multi-step, committee-based translation approach. Our
procedure was initially inspired by the TRAPD framework (18–20).
TRAPD is the acronym for five subsequent (but interrelated) phases:
Translation, Review, Adjudication, Pretesting and Documentation.
This framework is particularly in use in cross-cultural studies to
overcome cultural differences that are often an issue. Figure 1 shows
a detailed flow chart of the translation procedure. The translation
process started with two separate translations. One was considered
as main and one as secondary. The two translators worked
separately and independently. The first translator was a professional
interpreter whose mother tongue was English, who was fluent in
Italian and had been residing in Italy for several years. His work
was intended to provide the best possible rendering of the original
source into Italian, especially from the point of view of conceptual
and semantic equivalence [we classify equivalence according to
Herdman et al. (21, 22)]. This was considered as the main
translation. The second translator was a professional psychologist,
with a background in questionnaire design and analysis. His mother
tongue was Italian but he was fluent in English. His task was more
focused on disclosing issues regarding operational and measurement
equivalence. This was considered as a secondary translation, to be
used in suborder with respect to the first. A series of meetings
("team review & reconciliation” in Figure 1) was held to review the
two translations and the English source, and to reconcile all into a
suitable Italian version. A plastic surgeon, a nurse, the first
translator, and the project coordinator (who was also the secondary
translator) attended these meetings. The plastic surgeon and the
nurse worked at the same hospital where the study took place. Each
member of the team was provided with the translations and also
with the last Italian version of scale (10). The first draft was further
considered by the team ("team TCM screening"), in order to screen
adherence to Body perceived multidimensional schema (23) and to
examine issues of comprehensibility on behalf of patients (“Team
BPMS screening”). After the team reached an agreement, a first
reconciled Italian version was produced and discussed with the
original authors of the questionnaire. The draft copy was tested on
10 volunteers (patients with breast cancer) who received concise
information about the DAS and body-image perception, and then
ANTICANCER RESEARCH 36: 1519-1526 (2016)
1520
completed the questionnaire without supervision. The two translator
reviewed the completed questionnaire together with each
respondent, investigating missing data, problems of comprehension,
and possibly problematic wording. In this session, comments were
solicited from the respondents, and a further meeting discussed this
first phase. The retrospective debriefing round was followed by
cognitive debriefing interviews with another 15 volunteers. It was
also specifically verified that the polarity of response scales had
been correctly recognized. Based on these retrospective and
cognitive interviews, some variations concerning response scales
and their verbal descriptors were proposed. The variations were
reviewed by the medical doctor and the nurse ("variations &
clinicians’ review”) after a new discussion concerning the
framework, underlining the body perception multidimensional
schema (23). After the team review approved all the previous steps,
the draft copy was then employed, without changes, for testing in
pilot studies of the face validity and the internal consistency of the
scale’s items (clinical testing for psychometric properties). The
factorial structure of the hereafter termed DAS24ita and its
relationships with other theoretically related measures were then
assessed. The other measures include specific appearance-related
scale, and also a quality-of-life scale used to evaluate different
topics related to oncology patients, and breast cancer in particular.
Participants from the pilot studies and for the main study were both
recruited from the same hospital.
Pilot Studies
Face validity was preliminarily evaluated through a think-aloud
procedure in a sample of 25 volunteer patients with breast cancer
aged between 20 and 60 years (mean±SD=44.04±9.44 years). In
'think-aloud' interviews, the participants were asked to think aloud
as they answered questions, thus verbalizing the thoughts that would
normally remain silent during the process. Participants were not
asked to explain or justify what they were doing and were not asked
to report their strategies. Thought processes were then examined for
comprehension, recall and judgment difficulties. This methodology
can be useful in identifying the face validity of the measure and any
problematic questions, and can be repeated after a revision of the
instrument (24). 
Internal consistency was evaluated through Cronbach’s alpha on
a sample of 60 newly diagnosed patients with breast cancer aged
26-74 (mean±SD=45.22±9.27 years). Internal consistency of the
scale was demonstrated with Cronbach’s alpha of 0.93.
Main Study
Procedure. Data were collected at the Breast Cancer Department of
the G. Pascale National Cancer Institute in Naples, Italy. A booklet
containing the questionnaires was completed anonymously by
participants, or at a participant’s request, collected with the help of
a trained psychologist, who was also member of the research team.
The cover instruction page also reiterated the aim of project, the
ethical considerations, including the right of the participants to
withdraw, and an assurance of patient anonymity, and all
information about the study to ensure informed consent.
Participants. Ninety-three female participants were recruited, using
a computer-based randomised selection from the electronic clinical
database available at the Breast Cancer Department.
For confirmatory factor analysis, it is feasible either to follow
general rules for sample size, or use more specific guidance around
participant to variable ratios. Given a lower number of variables in
the confirmatory factor analysis reported here, it was feasible to
adopt a participant to variable ratio. Bryant and Yarnold (25) and
Gorush (26) both accept a ratio of 1:5 variables to participants. A
24-item scale would thus require 120 participants. The sample here
was less than this, although approaching it. Confirmatory factor
analysis results should thus be interpreted with caution.
The database includes patients at different stage of their cancer
treatment course (i.e. patients waiting for surgery and patients in
follow-up). For this study three group of patients were recruited: i)
patients waiting for breast cancer surgery (N=45, with no previous
treatments); ii) patients in follow-up of at least 12 months (range=12-
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Figure 1. Translation procedure. Flow chart detailing the subsequent steps for translation. The dotted line represents a possible feedback path which,
although originally considered, was ultimately found to be unnecessary. BPMS: Body perceived multidimensional schema.
16 months, mean=13.8 months) after conservative surgery (N=30);
and iii) patients in follow-up of at least 12 months (range=12-16
months, mean=14.2 months) after mastectomy (N=18). 
Inclusion criteria were: participants older than 18 years of age,
with a breast cancer diagnosis, of either sex, of Italian nationality.
Exclusion criteria were a psychiatric diagnosis, an objective
disfigurement identifiable by a trained psychologist, known
alcoholism or drug addiction. Patient data are shown in Table I.
Measures of the DAS24ita. The DAS24ita has the features of the
original scale (response options, introductory section). Some of the
items request a response about the intensity of emotional response,
using response categories of ‘extremely’ to ‘not at all’ (e.g. "How
distressed do you get when you see yourself in the
mirror/window?"). Other items ask about the frequency of particular
behaviours indicative of a self- conscious response (e.g. "I avoid
going out of the house"), using an ‘almost always’ to ‘never/almost
never’ set of response categories. The final two items, concerning
pain and functional limitation, are included at the request of medical
clinicians, which assess any physical impact of the problem of
appearance. These are for information only, and do not contribute
to the scoring of the scale.
In order to determine criterion validity, the patients were also
evaluated on different measures of appearance sensitivity, emotional
distress, and quality of life.
Appearance sensitivity measures. Body shame: The body shame
subscale of the Experience of Shame Scale (27) was used. It has four
items, rated on a 4-point scale ranging from 1 (nothing) to 4 (very
much), and requires the respondent to select the option that best
expresses the intensity to which they experienced each item in the
previous 3 months (e.g. "Have you avoided looking at yourself in the
mirror?"). The total score ranges between 1 and 4, with higher scores
indicating higher levels of shame. Cronbach’s alpha for the present
sample was 0.88.
Centre for Appearance Research Salience scale (CARSAL): The core
construct of salience was operationally defined as ‘‘the extent to
which appearance and physical self is brought into conscious
awareness.’’ The CARSAL item pool consisted of 10 items with
Likert scale response categories ranging from 1 (strongly disagree) to
6 (strongly agree). Three items were reverse scored. Higher scores
for each item indicated increased salience of appearance within the
self-concept – that is, appearance being part of the working self-
concept – than a lower score. Items for this scale were specifically
cognitive rather than affective or behavioural content. Cronbach’s
alpha for the present sample was 0.74.
Centre for Appearance Research Valence scale (CARVAL): The
core construct of valence was operationally defined as “The extent
to which the respondent evaluates her/his appearance in a
positive/negative way”. The item pool consisted of 12 items with
the same response options as the CARSAL. Seven of the candidate
items were reverse scored. Higher item scores indicated a more
negative evaluation of appearance. Items for this scale were
specifically affective and cognitive rather than behavioural. For both
scales, items were required to be applicable to objectively visibly
different and also other general population respondents. Cronbach’s
alpha for the present sample was 0.89. 
There are no published studies validating these scales in the
Italian language, hence for each of these scales, we used the same
translation procedure as used for the DAS scale. Other psychometric
properties are available upon request.
Emotional distress. The Hospital Anxiety and Depression Scale
(28) is a 14-item scale measuring current levels of depression and
anxiety. The Italian version has good psychometric qualities and
comprises two subscales: depression and anxiety, both with seven
items (29). It uses a 4-point scale (0-3) and the total score for each
subscale ranges from 0 to 21, with higher scores indicating more
symptomatology. Cronbach’s alpha for the present sample was 0.90.
Quality of life. Quality-of-life outcomes are extremely wide-
ranging, and have been described as encompassing almost all
aspects of a cancer patient’s well-being (30). In order to measure
the individual’s subjective perception of their quality of life, the
European Organization for Research and Treatment of Cancer
(EORTC) QLQ-C30 scale was used. This instrument was validated
for the Italian population according to the guidelines of the EORTC
QLQ group, and presented good reliability and validity (31). The
EORTC QLQ-C30 is a 30-item questionnaire composed of multi-
item scales and single items that reflect the multidimensionality of
the quality-of-life construct. It incorporates five functional scales
(physical, role, cognitive, emotional, and social), three symptom
scales (fatigue, pain, and nausea and vomiting), and a global health
and quality-of-life scale. The remaining single items assess
additional symptoms commonly reported by patients with cancer
(dyspnoea, appetite loss, sleep disturbance, constipation, and
diarrhoea), as well as the perceived financial impact of the disease
and treatment.
A tumour-specific questionnaire module (BR23 EORTC) was
used to supplement the QLQC30. This 23-item questionnaire
incorporates symptoms specifically relevant to breast cancer that are
not (adequately) addressed by the QLQC30 (33).
Data analysis. To examine the underlying constructs that the DAS24
is supposed to measure, a confirmatory factor analysis was
performed on our validation sample. Because other published
research of the DAS24 showed various factor solutions, we tested
two different confirmatory factor analysis models, one as proposed
by Carr et al. in their first validation study of the scale (one factor)
(9), and the second as recently proposed by Moss et al. (32) (two-
factor). The two different analyses were carried out in order to better
understand the structure being assessed by the DAS24 translation.
To establish criterion validity, the correlations between DAS24ita
and the other measures of appearance sensitivity were evaluated.
Because different studies dealing with body perception have focused
on the way in which alternative surgical treatments, especially in
breast cancer (33), can have different perceived outcomes, each of
the correlations was also calculated separately for each of the three
groups of patients based on operation type.
All analyses were carried out using SPSS Version 21.0 (SPSS,
Inc., Chicago, IL, USA), and Mplus-7 (Muthén&Muthén, Los
Angeles, CA, USA) (34).
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Table I. Patient age in years by intervention type.
Group N Min Max Median Std. deviation
No surgery 45 20.00 65.00 40.96 11.75
Quadrantectomy 30 26.00 68.00 46.03 11.34
Mastectomy 18 28.00 65.00 43.56 11.23
Results
Think-aloud procedure. One full iteration of revisions and
retesting was conducted before the survey instrument received
its final think-aloud test: one think-aloud session, followed by
refinements to the instrument, and one final think-aloud
session to confirm that all the issues had been remedied and
no new issues were being detected. Following identification
of the issues that emerged from the first think-aloud
procedure, a revision of the instrument underwent the last
think-aloud screening. At this point, we were satisfied that the
meaning of each of the items in the Italian translation was
consistent with the meaning, as originally presented in the
English language version. The face validity of the DAS24ita
was also confirmed at this stage.
Main study. The scoring of the scale was computed
according to standard scoring instructions (35). The
DAS24ita was evaluated to determine skewness, and exclude
floor or ceiling effects. Skewness was evaluated and found
to be non-significant (skew/st error skew=0.782/0.250).
The internal consistency of the single-factor scale
demonstrated a Cronbach’s alpha of 0.93. The mean of the
scale was 40.1, with standard deviation of 14.32.
Ninety-three participants provided data, with two missing
data entries for overall quality of life and 25 for breast-
related body image, as shown in Table II. 
Factor structure: Confirmatory factor analyses. The
adequacy of the single-factor structure of the DAS24
proposed by Carr et al. (9) and confirmed in other languages
(12), was examined with the DAS24ita. Confirmatory
factorial analyses, using MPLUS-7 software (34) was
conducted. As an alternative model, we also tested a recently
proposed bi-factorial model (32). In order to evaluate the
adequacy of the model, we considered the scale against a
variety of goodness of model-fit indices, including Tucker-
Lewis Index and Comparative Fit Index (CFI) (values close
to 0.95 indicate good fit); root mean-square error of
approximation (RMSEA) value of less than 0.06 indicates
good fit (36), and a χ2/df ratio of less than 2 (37). 
As shown in Table III, the one-factor model provided the
better fit to the data. Cautious interpretation of these findings
are required on a sample this size. 
Convergent criterion validity. The DAS24ita demonstrated
significant correlations with the other measures of
appearance sensitivity, including the CARSAL (r=0.37,
p<0.05), as well as the CARVAL (r=0.63, p<0.001) and
body shame (r=0.82, p<0.001) scales. 
The DAS24ita demonstrated positive strong association with
measures of anxiety (r=0.55) and depression (r=0.73) (both
p<0.001), an inverse relationship (r=−0.30, p<0.01) with the
Global Health Status subscale of EORTC QLQ-C30, and the
Body Image subscale of BR23 EORTC (r=0.74, p<0.001). 
Concurrent criterion validity. In order to examine the
concurrent criterion validity, the ability of the DAS24ita to
discriminate amongst preoperative, quadrantectomy, and
mastectomy patients was examined (see Table IV for
summary descriptive statistics). Differences between these
three groups for other relevant variables (body shame,
appearance salience and valence, anxiety, and depression)
were also examined to establish that the groups were
meaningfully different.
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Table II. Descriptive statistics for key variables used in the study.
DAS24ita CARVAL CARSAL Body shame QoL Body image Anxiety Depression 
Mean 40.14 23.5 19.4 8.6 63.8 61.03 11.9 9.5
N 93 93 93 93 91 68 93 93
Std. deviation 14.3 7.1 4.2 3.6 29.1 30.8 5.5 5.5
DAS24ita: Derriford Apperance Scale 24 in Italian; CARVAL: Centre for Appearance Research Valence scale ; CARSAL: Centre for Appearance
Research Salience scale; QoL: quality of life measured with the European Organization for Research and Treatment of Cancer scale version QLQ30.
Table III. Best model fitting between one-factor and bi-factorial solution
of the DAS24ita.
Test of model fit One-factor Bi-factorial 
structure structure
Chi-square value 348.75 529.17
Degrees of freedom 230 252
p-Value <0.001 <0.001
CFI 0.882 0.739
TLI 0.871 0.714
RMSEA 
Estimate 0.075 0.109
90% CI 0.058-0.090 0.096-0.122
Probability RMSEA ≤0.05 0.009 <0.0001
SRMR 0.066 0.255
CFI/TLI: Comparative Fit Index/Tucker-Lewis Index; CI: confidence
interval; RMSEA: root mean-square error of approximation; SRMR:
standardized root mean-square residual.
A Kruskal–Wallis H-test was run to determine if there
were differences between each of the three groups, no
surgery (n=45), quadrantectomy, (n=30 other than for quality
of life, when n=28) and mastectomy (n=18) across all the
measured variables. Distributions of scores for each of the
variables were not similar for all groups, as assessed by
visual inspection of a boxplot. Subsequently, pairwise
comparisons were performed using Dunn's (38) procedure
with a Bonferroni correction for multiple comparisons.
DAS24ita, body shame, and depression variables had a
similar pattern in the three treatment groups. The
distributions of DAS24ita scores were statistically
significantly different between groups (χ2(2)=39.0, p<0.001).
All groups were statistically different from each other at
p<0.05. No surgery scored lower (better adjustment) than
quadrantectomy, which was also significantly lower than
mastectomy (poorest adjustment).
The distributions of body shame scores were statistically
significantly different between groups (χ2(2)=37.4, p<0.001).
Again, each group was significantly different from the others in
body shame (p<0.02), with a similar pattern to DAS24ita scores.
The distributions of depression scores were statistically
significantly different between groups (χ2(2)=36.54,
p<0.001). All groups were significantly different to each
other (p<0.05), following the same pattern as DAS24ita
scores and body shame scores.
Quality of life scores followed the same broad pattern as
DAS, body shame and depression, but the size of differences
between the quadrantectomy and the other two groups did
not reach significance. The distributions of quality of life
scores were statistically significantly different between
groups (χ2(2)=6.46, p<0.039). Only the mastectomy and no
surgery groups were significantly different from each other
(no surgery significantly lower); the quantrantectomy group
had an intermediary score and was thus not significantly
different from either. 
CARVAL, anxiety, and breast-related body image followed
a similar pattern to each other. The distributions of CARVAL
scores were statistically significantly different between
groups, (χ2(2)=16.7, p<0.001). The scores for the no-surgery
group was significantly lower than both of the other groups,
which did not differ significantly from each other.
The distributions of anxiety scores were statistically
significantly different between groups (χ2(2)=27.61,
p<0.001). The no surgery group had significantly lower
anxiety than both the surgical groups, which did not differ
from each other.
The distribution of breast-related body image scores were
significantly different between groups (χ2(2)=30.80,
p<0.001). The no surgery group had significantly better
breast-related body image than both the surgical groups,
which did not differ from each other.
The distributions of CARSAL scores were not statistically
significantly different between groups (χ2(2)=1.43, p=0.489).
Discussion
The translation of the DAS24 from English to Italian was
successful. The Italian scale was internally valid, and had
appropriate criterion validity, correlating with measures of
appearance sensitivity, body shame, depression, anxiety, and
quality of life. The concurrent criterion validity was
demonstrated by an investigation of the impact of surgery
upon psychological outcomes. It is worth elaborating upon
these results.
DAS24ita, body shame and depression scores had similar
patterns – mastectomy was associated with poorer outcomes
than quadrantectomy, which itself is associated with poorer
adjustment than pre-treatment. Appearance valence
(CARVAL) and anxiety scores were not different across the
two surgery groups, but both differed from the pre-treatment
group. Global quality of life was only different between pre-
treatment and mastectomy groups.
This pattern of results is a vindication of the translation
process for DAS24ita. It further demonstrates the predicted
pattern of outcomes from pre-operative, quadrantectomy,
and mastectomy patients, which is supported by the impact
on body shame and depression. The difference between pre-
treatment patients and surgical patients in anxiety and
appearance valence is broadly consistent with this, although
it invites the further investigation of why quadrantectomy
and mastectomy are not differentiated by these measures.
We can speculate that the component of DAS24ita, body
shame and depression which differentiates these measures
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Table IV. Descriptive statistics by surgery type.
DAS24ita CARVAL CARSAL Body shame Sexual functioning Anxiety Depression
No surgery 32.33 20.69 19.18 6.69 9.17 8.76 6.38
Quadrantectomy 40.2 24.83 19 8.93 41.11 14.7 10.73
Mastectomy 59.56 28.11 20.39 13.06 17.59 14.94 15.5
DAS24ita: Derriford Appearance Scale 24 in Italian; CARVAL: Centre for Appearance Research Valence scale; CARSAL: Centre for Appearance
Research Salience scale.
from anxiety and appearance valence is the personal, non-
social aspect of bodily difference (what one is) as opposed
to the social aspect of bodily difference (how one deals
with others in social and interpersonal settings); we can at
this stage only offer this as a hypothesis for future
investigation. The fact that the quadrantectomy patients
scored at a mid, and non-significantly different, level
compared to pre-treatment and mastectomy suggests that
any effect on global quality of life was small, and may
become statistically significant with a larger sample.
Whether clinical significance was observed remains a moot
point. The breast-related body image scores were broadly
consistent with expectations, in that the pre-surgery group
had better scores than post-surgery groups.
The implications of this work are important for surgeons
and their patients. Firstly, we are confident that the Italian
language version of the DAS24 scale is valid and internally
consistent. It offers a short, sensitive and specific outcome
measure in plastic and reconstructive surgery for Italian-
speaking patients. For patients, it provides an opportunity to
record and raise issues with their surgeon which may not
otherwise be covered in a clinical setting, as has been
reported in the initial use and development of the scale by
Carr et al. (9). In this way, the patient is empowered to raise
sensitive issues, and the surgeon has a means of ensuring that
psychological needs are not missed. It also serves as an
effective outcome measure for the psychological success of
surgical interventions, and allows calculation of clinical cost
and cost effectiveness of interventions.
There are a number of limitations to this work which are
worth considering. The sample size was sufficient for the
analysis of internal validity and for the tests of criterion
validity. It was on the lower permissible size for the
confirmatory factor analysis, according to Arrindel and van
der Ende (39), however we counsel caution in interpreting
the confirmatory factor analysis results, and recommend
replication on a larger sample. Nonetheless, the past and
recent literature on this topic brings results recommending
different numbers of subjects, or ratio of subject to
variable/items. In our study the ratio was 3.9:1, which could
be considered the lower bound of an acceptable ratio by
Arrindel and van der Ende (39), and deeply discussed by
Khalid, in a review of other studies conducting factor
analysis with a ratio below 3:1 (40).
Furthermore, there is a need for developing cross sectional
designs such as this and implementing longitudinal studies
to develop a clearer understanding of change over time.
Finally, there is a hypothetical chance of a confounding of
the design by differential diagnosis for the quadrantectomy
and mastectomy patients, which may in part explain the
difference between the outcomes for these groups. However,
from a psychosocial perspective, there is no a priori reason
for expecting this to be a factor.
This study has demonstrated an effective translation and
validation of the Derriford Appearance Scale 24 from English
into Italian. The translated scale was able to differentiate
amongst patients with differential diagnoses, and was more
sensitive to these differences than generic quality-of-life scales.
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